|
|
|
Volumn 114, Issue 10, 2006, Pages 611-622
|
|
2006 DVO-guideline for prevention, diagnosis, and therapy of osteoporosis for women after menopause, for men after age 60 executive summary guidelines
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTONEL PLUS KALZIUM;
ALENDRONIC ACID;
ALFACALCIDOL;
ANALGESIC AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CALCITONIN;
CALCIUM;
COLECALCIFEROL;
ESTROGEN;
ETIDRONIC ACID;
FLUORIDE;
GLUCOCORTICOID;
IBANDRONIC ACID;
LEVOTHYROXINE;
NANDROLONE DECANOATE;
PARATHYROID HORMONE[1-34];
PROGESTERONE;
RALOXIFENE;
RISEDRONIC ACID;
SEDATIVE AGENT;
STRONTIUM RANELATE;
UNCLASSIFIED DRUG;
AGE DISTRIBUTION;
ANAMNESIS;
BONE BIOPSY;
BONE DENSITOMETRY;
BONE PAIN;
CIGARETTE SMOKING;
COORDINATION;
DIET SUPPLEMENTATION;
DRUG CONTRAINDICATION;
ESOPHAGITIS;
FALLING;
FEMALE;
HIP FRACTURE;
HOT FLUSH;
HUMAN;
HYPOCALCEMIA;
HYPOPHOSPHATEMIA;
IMMOBILIZATION;
LABORATORY TEST;
LETTER;
LIFESTYLE;
LOW DRUG DOSE;
MALE;
MULTIPLE CYCLE TREATMENT;
MUSCLE STRENGTH;
OSTEOPOROSIS;
PATIENT MONITORING;
POSTMENOPAUSE OSTEOPOROSIS;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEX DIFFERENCE;
SIDE EFFECT;
TREATMENT DURATION;
UNDERWEIGHT;
VASODILATATION;
VERTEBRA FRACTURE;
FEMALE;
HUMANS;
MALE;
MENOPAUSE;
MIDDLE AGED;
OSTEOPOROSIS;
PRACTICE GUIDELINES;
|
|
EID: 33846168056
PISSN: 09477349
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (32)
|
|
References (0)
|
